about
Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomasThe impact of sphingosine kinase-1 in head and neck cancer.Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma.Ras in cancer and developmental diseasesSignaling mechanisms in neuroendocrine tumors as targets for therapy.Hypoxia-inducible factor in thyroid carcinomaApplication of metabolomics in thyroid cancer research.BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature ReviewIdentification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningAssociation between microRNA polymorphisms and papillary thyroid cancer susceptibility.RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinomaSignaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.Molecular challenges of neuroendocrine tumors.CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma.
P2860
Q28263577-C76EFC3B-8647-4802-9BF5-E89778CB68AFQ28475549-B253FE92-C136-4533-8F28-B0B8C1CBA9ECQ33649748-B0CA82AD-E49F-4642-AD23-865872FC6898Q33860459-69578D5D-F572-4821-B776-F26CC85ED0C1Q34202697-B07B646D-9989-4B88-BEF9-217D21AF7731Q34447484-5A73771E-A3D4-4B34-8BEC-3315F19DA1B1Q35099457-B89ACE1C-3E0F-4E11-9A4E-EC0F9B2B6594Q35564078-00F260E0-FFA5-411C-8151-F3ED2F02CEA4Q35609167-7970BD08-C3BC-4A37-A770-9A8EBBA8BF14Q35797331-0CA788AE-0844-450A-9C12-029F8872D081Q35883006-59203977-6DF8-4354-92B8-9B7DB5CF664AQ35971877-C301FE55-E378-4291-8578-6C8DA89E6239Q36348701-AB53CE72-ED93-4F0E-8A79-AF76B6AD3749Q37985518-1F6DC566-C25B-4202-9F8F-30C6CEB399EEQ40720717-7B908F2E-5D5A-41EE-A050-45431F712C55Q42245179-6C51B17E-CB64-485C-9133-109CCA448E4FQ49875027-D5F71510-9C9F-4DFC-88DD-EE02841FDF40Q55229133-788C82B4-BC0D-4B24-AA74-68B266BC1A54
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular pathology of differentiated thyroid cancer.
@en
Molecular pathology of differentiated thyroid cancer.
@nl
type
label
Molecular pathology of differentiated thyroid cancer.
@en
Molecular pathology of differentiated thyroid cancer.
@nl
prefLabel
Molecular pathology of differentiated thyroid cancer.
@en
Molecular pathology of differentiated thyroid cancer.
@nl
P2093
P1476
Molecular pathology of differentiated thyroid cancer
@en
P2093
Borrello MG
Degl'Innocenti D
P304
P577
2009-10-01T00:00:00Z